• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Central Nervous System Insomnia or Sleep Disorders Product Image

Central Nervous System Insomnia or Sleep Disorders

  • ID: 599487
  • March 2008
  • 172 pages
  • Life Science Analytics

"Central Nervous System Insomnia or Sleep Disorders " contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each ’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report READ MORE >

--Recent Highlights and Changes
Insomnia or Sleep Disorders Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Insomnia or Sleep Disorders Projects
--BTG plc
--Barr Pharmaceuticals Inc
--Dainippon Sumitomo Pharma Co., Ltd.
--Cortex Pharmaceuticals Inc
--Eli Lilly & Co
--Dov Pharmaceutical Inc
--Fabre-Kramer Pharmaceuticals, Inc.
--Evotec AG
--Merck & Co Inc
--Intra-Cellular Therapies, Inc.
--Neurim Pharmaceuticals Ltd.
--Mylan, Inc.
--Neurogen Corporation
--Neurocrine Biosciences Inc
--Pfizer Inc
--Orexo AB
--Ranbaxy Laboratories Ltd.
--Vanda Pharmaceuticals Inc
--Takeda Pharmaceutical Company Limited

--Top Companies in early stage Insomnia or Sleep Disorders Projects
--Alexza Pharmaceuticals Inc
--Abeille Pharmaceuticals, Inc.
--BiRDS Pharma AG
--BioDelivery Sciences International Inc
--Merck & Co Inc
--Johnson & Johnson
--Neurocrine Biosciences Inc
--Neurim Pharmaceuticals Ltd.
--Pfizer Inc
--Omeros Corporation
--Prestwick Pharmaceuticals, Inc.
--Pherin Pharmaceuticals, Inc.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View

Note: Product cover images may vary from those shown


Our Clients

Our clients' logos